Lofepramine

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Neuro-developmental disorders ADHD (Attention deficit hyperactivity disorder): Diagnosis Heuvelman, 2023 11.74[0.82; 3.68]-296not evaluable ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk Heuvelman, 2023 11.74[0.82; 3.68]-296not evaluable ASD (Autism spectrum disorder): Diagnosis Heuvelman, 2023 12.52[1.23; 5.17]-296not evaluable ASD (Autism spectrum disorder): Diagnosis/Risk Heuvelman, 2023 12.52[1.23; 5.17]-296not evaluable Cognitive developmental disorders/delay (> 6 years old) Heuvelman, 2023 11.88[0.72; 4.88]-296not evaluable Severe cognitive developmental delay (Mental retardation) (> 6 years old) Heuvelman, 2023 11.88[0.72; 4.88]-296not evaluable0.510.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons